Purdue Pharma, based in New York, NY, is a pharmaceutical company undergoing restructuring following a Supreme Court decision in December 2023. Despite the court ruling against third-party releases in the Plan of Reorganization, Purdue remains committed to using settlement funds for opioid abatement and transitioning towards a socially responsible mission. The company continues to collaborate with creditors to negotiate a new settlement that aligns with these objectives.
Operational stability and medication production remain unaffected by the Supreme Court’s decision, ensuring uninterrupted service to patients and partners. Purdue Pharma emphasizes patient-centric drug development, aiming to introduce innovative medications that enhance and save lives. The company's dedication to research and development underscores its enduring commitment to supporting healthcare professionals, patients, and caregivers.
Generated from the website content